NATERA, INC. Restricted Cash and Cash Equivalents, Noncurrent
NATERA, INC. (NTRA) had Restricted Cash and Cash Equivalents, Noncurrent of $342.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2019-03-15
- 2018-09-30: Restricted Cash and Cash Equivalents, Noncurrent $342.00K.
- 2018-06-30: Restricted Cash and Cash Equivalents, Noncurrent $342.00K.
- 2018-03-31: Restricted Cash and Cash Equivalents, Noncurrent $342.00K.
- 2017-12-31: Restricted Cash and Cash Equivalents, Noncurrent $342.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2018-09-30 | $342.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $342.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $342.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $342.00K 10-K · filed 2019-03-15 |
| 2017-09-30 | $342.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $342.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $342.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $342.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | $342.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $342.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $342.00K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $683.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $1.43M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $1.43M 10-Q · filed 2015-08-13 |
| 2014-12-31 | $808.00K 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |